Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating stereotactic body radiation therapy for oligometastatic renal cell carcinoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 2 | Status: SUSPENDED